홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VKTX
#1446
Viking Therapeutics, Inc
35.3
9
USD
+1.09%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.09%
월간 변동
+0.25%
6달 변화
+5.26%
년간 변동율
+44.15%
이전 종가
35.0
1
Open
35.6
2
Bid
Ask
Low
35.3
8
High
35.6
2
양
294
마켓
주식
헬스케어
VKTX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
74.13 M
78.36 M
78.42 M
100.49 M
112.25 M
115.55 M
—
Valuation ratios
Enterprise value
388.25 M
334.1 M
631.49 M
1.78 B
4.49 B
3.9 B
12.39 B
Price to earnings ratio
-10.35
-6.46
-9.47
-20.09
-39.84
-11.03
-61.39
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
-18.77
-7.46
-13.53
-23.5
-49.98
-14.22
-66.61
Price to book ratio
1.67
1.76
4.5
4.95
4.98
6.2
8.71
EBITDA 비율에 대한 기업 가치
—
—
—
-16.34
-26.7
-9.68
-46.75
Profitability ratios
Return on assets %
-0.15
-0.26
-0.41
-0.23
-0.12
-0.5
-0.47
Return on equity %
-0.16
-0.27
-0.47
-0.25
-0.12
-0.56
-0.51
Return on invested capital %
-11.89 K
-50 K
-28.78 K
-23.85 K
-37.93 K
-169 K
-163.15 K
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
21.12
23.98
7.61
19.19
33.09
9.33
107.78
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.3
-0.62
-0.63
-0.78
-0.81
-2.47
-2.48
EBIT per share
-0.59
-0.72
-0.92
-1.07
-1.38
-3.49
-3.5
EBITDA per share
—
—
—
-1.16
-1.54
-3.57
-3.58
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.42
2.62
2.02
3.84
8.28
6.26
27.43
Net current asset value per share
3.53
2.73
2.17
3.89
8.32
6.35
28.03
Tangible book value per share
3.37
2.62
1.89
3.69
8.07
5.67
26.67
Working capital per share
3.36
2.61
1.89
3.69
8.07
5.67
26.66
Book value per share
3.37
2.62
1.89
3.69
8.07
5.67
26.67
뉴스
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing
NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?
LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships
3 Best Stocks Under $50 to Buy in April 2026, According to Analysts - TipRanks.com
Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?
WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks
VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?
Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial